Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

LA County will require 'superbug' reports

A new law in California will require hospitals in Los Angeles County to report incidence of certain “superbugs,” the Los Angeles Times reported. California is one of roughly half the U.S. states that had not required the reporting in the past. 

CMS: Mylan overcharged government for EpiPens for years

The controversy over the price increases for EpiPens isn’t going away, as Mylan is now being accused by CMS of overcharging Medicare and Medicaid by classifying the autoinjector as a generic drug.

Tracing the history of Trump and Clinton’s health plans

While much of the 2016 presidential election appears to defy historical trends, the origins of the health policies put forward by the two candidates can easily be traced back to the mid-20th century, according to a column in the New England Journal of Medicine.

Anthem-Cigna trial split up for faster ruling

The national and local market implications of the $54 billion proposed merger of Anthem and Cigna will be considered separately, potentially expediting the court decision on the case.

FTC recommends rejecting Virginia hospital merger

Virginia regulators should deny the proposed merger of Mountain States Health Alliance and Wellmont Health System, according to testimony from the Federal Trade Commission (FTC).

2.5 million people may be missing out on ACA subsidies

An analysis from HHS said millions of additional customers could qualify for subsidies if they purchased plans off the Affordable Care Act (ACA) marketplace.

Kentucky gets OK to dismantle state exchange site

Another state is moving to the federal Healthcare.gov marketplace rather than running its own exchange, after Kentucky has been given permission to shut down kynect, its state-run site.

Uneven ground: Freestanding EDs face patchwork regulation

While freestanding emergency departments (EDs) are becoming more popular, regulations and requirements on these facilities vary widely between states, which may lead to facilities being built where they’re not needed.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.